Medical information Clinical review pending

Genetic Testing

PRPS1 Gene Phosphoribosylpyrophosphate Synthetase Superactivity Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to analyze the PRPS1 gene for mutations associated with metabolic disorders. Helps identify phosphoribosylpyrophosphate synthetase superactivity.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card. Confirm specific requirements with the laboratory before booking.
Results: Approximately 3 to 4 weeks. Confirm current turnaround time with the laboratory before booking.
Preparation: A clinical history of the patient is required. A genetic counseling session to create a pedigree chart of affected family members is recommended prior to testing. No fasting is typically required, but confirm with the laboratory.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the PRPS1 Gene Phosphoribosylpyrophosphate Synthetase Superactivity Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Symptoms suggestive of a metabolic disorder
✓Family history of metabolic disorders
✓Unexplained neurological issues
✓Growth and developmental delays
✓Recurrent gout or kidney stones (in some cases)
✓Evaluation of purine metabolism disorders

In plain language

What this test helps you understand

Identifies genetic mutations in the PRPS1 gene associated with phosphoribosylpyrophosphate synthetase superactivity and related metabolic disorders. Aids in diagnosis and understanding of genetic predispositions.

The PRPS1 Gene Phosphoribosylpyrophosphate Synthetase Superactivity NGS Genetic DNA Test is a diagnostic tool used to identify genetic mutations linked to metabolic disorders. This test utilizes Next-Generation Sequencing (NGS) technology for a detailed analysis of the PRPS1 gene. This gene is important for nucleotide biosynthesis, and understanding its function is key to diagnosing conditions that can cause various health problems.

This genetic test assesses the activity of the PRPS1 gene and looks for mutations that might cause phosphoribosylpyrophosphate synthetase superactivity. Increased activity of this enzyme can lead to metabolic imbalances and significant health issues.

Individuals showing symptoms related to metabolic disorders, or those with a family history of such conditions, may benefit from this test. Symptoms can include unexplained fatigue, neurological issues, and growth or developmental delays. A family history of metabolic disorders or related genetic conditions is also a risk factor.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationA clinical history of the patient is required. A genetic counseling session to create a pedigree chart of affected family members is recommended prior to testing. No fasting is typically required, but confirm with the laboratory.

SampleBlood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card. Confirm specific requirements with the laboratory before booking.

MethodologyNext-Generation Sequencing (NGS) of the PRPS1 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test analyzes specific regions of the PRPS1 gene. It may not detect all possible mutations, such as deep intronic changes or large deletions/duplications, unless specifically requested. Results must be interpreted alongside clinical findings.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

The PRPS1 gene provides instructions for making an enzyme called phosphoribosylpyrophosphate synthetase 1. This enzyme is involved in the process of building blocks for DNA and RNA.

Superactivity refers to an enzyme being overly active. In the case of PRPS1, excessive activity can lead to an overproduction of certain molecules, causing metabolic imbalances.

Individuals with symptoms suggestive of a metabolic disorder, a family history of such conditions, or specific clinical findings like recurrent gout or kidney stones may be recommended for this test.

Results are interpreted by qualified professionals, often genetic counselors or specialists. They will explain the findings in relation to your health history and discuss potential implications.

Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.

Please contact the laboratory directly via phone or WhatsApp at +254711564616 to book your test or inquire about online booking options.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp